TELA Bio (TELA) Gross Margin (2018 - 2026)

TELA Bio's Gross Margin history runs 9 years deep, the most recent figure standing at 65.69% for Q1 2026.

• On a quarterly basis, Gross Margin fell 187.0% year-over-year to 65.69% in Q1 2026; TTM through Mar 2026 was 67.25%, a 32.0% increase from a year earlier, with the FY2025 full-year figure at 67.69%, up 61.0% from the prior year.
• Gross Margin steadied at 65.69% in Q1 2026 per TELA's latest filing, from 65.91% in the prior quarter.
• Across five years, Gross Margin topped out at 70.38% in Q2 2023 and bottomed at 60.73% in Q1 2022.
• The 5-year median for Gross Margin is 67.56% (2025), against an average of 66.98%.
• Across the five-year window, Gross Margin soared 744 bps in 2023 and sank 481 bps in 2024, its largest moves.
• Year by year, Gross Margin stood at 70.35% in 2022, then decreased by 3 bps to 68.38% in 2023, then dropped by 7 bps to 63.58% in 2024, then grew by 4 bps to 65.91% in 2025, then fell by 0 bps to 65.69% in 2026.
• Per Business Quant, the three latest TELA Gross Margin figures stand at 65.69% (Q1 2026), 65.91% (Q4 2025), and 67.52% (Q3 2025).